NJOY has two existing devices that have received marketing approval from the US Food and Drug Administration. The regulator today issued marketing authorisation orders (MGO) for 4.5% of NJOY Daily Rich Tobacco and 6% of NJOY Daily Extra Rich Tobacco under the Premarket Tobacco Products Application (PMTA) process.
"It should be noted that we determined that the marketing of these products was based in part on submitted microbial stability data under APPH [For protection of Public Health]," MGO said. "The issuance of these marketing authorizations confirms that you have met the requirements of Section 910(c) of the FD&C Act and authorizes the marketing of your new tobacco products."
The agency said the designation does not mean the products are safe or "FDA-approved," but MGO allowed the company to legally sell them in the United States.
"We found that allowing the sale of new products as APPH does not mean that FDA has' approved 'the new tobacco products specified in Appendix A," MGO said. "Therefore, you may not make any statement or representation, express or implied, on labels, labels, or through media or advertising that the new tobacco products designated in Appendix A have been approved by the FDA."
FDA has also issued multiple marketing denial orders (Mdos) to NJOY for other Daily e-cigarette products. These are assumed to be used in flavoring products other than tobacco. Any products left on the market must be removed or risk FDA enforcement, the agency said. Applications for two mint flavored daily products are still under FDA review.
In addition, the authorization imposes strict marketing restrictions on companies to greatly reduce the likelihood that teens will be exposed to tobacco advertising for these products. The FDA said it will closely monitor how these products are marketed and will take necessary action if companies fail to comply with any applicable legal or regulatory requirements or if the number of nonsmokers, including adolescents, increases significantly.
On April 26, FDA authorized four NJOY Ace products through the PMTA pathway.

